Canonical RIP1-RIP3-MLKL-mediated necroptosis is implicated in multiple human diseases, including in the progression of non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) (1–3). This evidence concerns the gene RIPK3 and metabolic dysfunction-associated steatohepatitis.